In diabetes, the retina, a tissue with unique metabolic needs, demonstrates dysregulation of the intricate balance between nutrient availability and utilization. This results in cholesterol accumulation, pro-inflammatory and pro-apoptotic changes, and consequently neurovascular damage. Sirtuin 1 (SIRT1), a nutrient sensing deacetylase, is downregulated in the diabetic retina. In this study, the effect of SIRT1 stimulation by fasting or by pharmacological activation using SRT1720, was evaluated on retinal cholesterol metabolism, inflammation and neurovascular damage. SIRT1 activation, in retinal endothelial cells (REC) and neuronal retinal progenitor cells (R28), led to Liver X Receptor alpha (LXRα) deacetylation and subsequent increased activity, as measured by increased ATP-binding cassette transporter (ABC) A1 and G1 mRNA expression. In turn, increased cholesterol export resulted in decreased REC cholesterol levels. SIRT1 activation also led to decreased inflammation. SIRT1 activation, in vivo, prevented diabetes-induced inflammation and vascular and neural degeneration.
mechanistic link between the advantageous effects associated with fasting regimes and prevention of diabetic retinopathy (DR).
Introduction
The high metabolic demands of the retina dictate complex regulatory pathways needed to meet retinal energy needs while preserving autonomy behind the blood-retina barrier (BRB).
Healthy retinal function is maintained by a delicate balance between nutrient availability and tightly regulated retinal lipid metabolism (1) . However, in a diabetic environment, characterized by chronic low-grade inflammation and lipid accumulation, the balance between nutrient availability and retinal-specific metabolism may be lost (2) (3) (4) . One of the major consequences of dysregulation of lipid metabolism is elevated retinal cholesterol levels, ultimately fostering the progression of DR, the most common microvascular complication (5, 6 ).
Previously we, and others, have demonstrated the advantageous effects of activation of cholesterol regulating mechanisms in the prevention of DR progression. Specifically, we have shown that activation of LXRα in the diabetic retina, by synthetic ligand administration, stimulates the reverse cholesterol transport (RCT) pathway resulting in decreased retinal cholesterol accumulation (7, 8) . Additionally, activation of the LXRα signaling cascade reduces diabetes-induced inflammation by repressing the NF-kβ response element on inflammatory genes such as IL-1β and IL-6 (7). Consequently, due its ability to regulate retinal cholesterol levels and anti-inflammatory properties, activation of LXRα signaling effectively prevents DR progression in vivo. However, activation of LXRα by pharmacological ligands, have the potential to cause a compensatory increase in expression of SREBP1c and ChREBP resulting in hypertriglyceridemia and liver steatosis (9, 10) . Thus, additional efforts for identifying alternative mechanisms of LXRα activation are warranted.
In addition to ligand binding, LXRα can be activated via deacetylation. SIRT1 deacetylase is a major controller of LXR acetylation status (11) . We have previously shown that pharmacological SIRT1 activation, in vitro, results in elevation of LXRα mediated signaling (7) . SIRT1 is a NAD + -dependent nutrient sensing deacetylase and is activated in nutrient scarce conditions (12, 13) .
SIRT1 is uniquely positioned to sense a tissues metabolic status and fine tune tissue demands to maintain a homeostatic balance.
Due to the importance of SIRT1-mediated signaling in metabolism, deregulation of SIRT1 deacetylase activity results in chronic metabolic abnormalities. For instance, in diabetes, SIRT1
expression and activity are significantly decreased (14, 15) . In the diabetic retina, activation of SIRT1 is protective against diabetes-induced vascular and mitochondrial damage by inhibiting MMP-9 activation (14) . Importantly, diabetes-induced decreases in SIRT1 signaling results in dysregulated cholesterol metabolism and increased production of pro-inflammatory cytokines via decreased LXRα signaling (7) . However, in vitro under diabetes mimicking conditions, pharmacological activation of SIRT1 prevents increases in cholesterol accumulation and inhibits inflammation by activating LXRα signaling (7) .
Due to SIRTs dependence on NAD + , a strong association has been made between SIRT activation and periods of low nutrient availability. Fasting regimes and SIRT1 activation have been shown to increase longevity and delay onset of disease in yeast, fruit flies, mice and more recently, non-human primate animal models (12, 16, 17) . Fasting-induced SIRT1 activation has been linked to increased NAD + levels, increased mitochondrial biogenesis and delayed senescence (17) (18) (19) . Additionally, we showed that chronic intermittent fasting prevents the development of DR and extends longevity by restructuring the microbiome of type 2 diabetic animals (20) . The mechanisms regulating these beneficial outcomes include the increased generation of endogenous oxysterols and their activation of the nuclear receptor TGR-5 within the retina; however additional mechanisms are under active investigation.
The current study was designed to determine the role of the SIRT1/LXRα signaling pathway in prevention of DR. Pharmacological agents were used to activate SIRT1 both in in vitro and in vivo models as well as fasting mimicking conditions (FMCs) in vitro. SIRT1/ LXRα signaling was examined by measuring RCT activation and inhibition of NF-Kβ-dependent proinflammatory gene production. Thus, modulation of nutrient availability and subsequent SIRT1/LXR activation, provides an innovative mechanism to prevent DR.
Results

Diabetes-induced retinal cholesterol accumulation and inflammation is prevented by SIRT1 activation
The diabetic retinal milieu is characterized by increased levels of inflammation and cholesterol accumulation. Moreover, SIRT1/LXR signaling is significantly decreased in diabetesassociated complications, including DR (7, 21) . In order to investigate the effect SIRT1 activation on DR progression, control and db/db animals were fed chow containing the selective SIRT1
activator, SRT1720 (100mg/kg body weight/day) for 6 months following the onset of diabetes.
Diabetes significantly reduced SIRT1 retinal expression. However, retina isolated from mice fed SRT1720-containing chow had increased retinal SIRT1 expression, with preservation of the ganglion cell layer (GCL) when compared to retinas from diabetic mice fed control chow (Figure
1A-D).
SIRT1 has been previously shown to deacetylate, and subsequently, activate LXR. Increased SIRT1/LXR signaling led to increased levels of RCT, via upregulation of ABCA1 and ABCG1, and upregulation of anti-inflammatory gene expression (7) . As expected, diabetes resulted in elevated retinal cholesterol levels when compared to control retinas. SIRT1 activation, via SRT1720, restored cholesterol levels in diabetic retina to non-diabetic levels ( Figure 1E ).
Treatment with SRT1720 also alleviated diabetes-induced inflammation, as measured by expression of IL-1β, CCL-2 and Iba-1 + and CD45 + cells (Figure 1F-H) . Moreover, activation of SIRT1 signaling, prevented diabetes-induced downregulation of ABCG1 expression in antiinflammatory M2 macrophages (supplemental material S1A).
SIRT1 activation prevents retinal vascular and neurodegeneration in vivo.
Formation of acellular capillaries is the hallmark feature of DR. As shown in Figure 1I , the development of acellular capillaries was significantly increased in db/db mice (red arrows).
Activation of SIRT1, via SRT1720 treatment, restored the number of acellular capillaries to nondiabetic levels ( Figure 1K-L) . Neuronal damage and loss (Figure 2 ) precede the microangiopathy of DR. As expected, diabetes resulted in a loss of neurons as measured by NeuN + immunohistochemistry analysis ( Figure 2B ). However, administration of SRT1720 significantly preserved NeuN + expression, predominately localized in the retinal ganglion cell layer ( Figure 2C ).
Fasting-mimicking conditions activate SIRT1/LXR signaling in vascular cells and neuronal cells.
SIRT1 is activated by low nutrient, calorie reduced physiological states. In addition to pharmacological activation of SIRT1, via SRT1720, fasting mimicking conditions (FMCs) (0% FBS) activated SIRT1 expression and histone deacetylase (HDAC) activity in REC ( Figure 3A) .
Consequently, increased HDAC activity resulted in elevated total LXRα protein levels and activity, as measured by expression of ATP-binding cassette transporter A1 and G1 ABCA1,ABCG1; respectively)( Figure 3B ). Moreover, total and active LXRα protein levels were significantly increased in REC treated with FMC ( Figure 3D-F) .
As shown in Figure 4A , REC administrated TNFα which is typically increased in diabetes, resulted in increased cholesterol levels. In contrast, FMC lowered cholesterol accumulation in REC (supplemental material S1B). As expected, activation of LXRα via DMHCA, a steroidal LXR ligand, significantly reduced REC cholesterol levels. Treatment with FMC, in combination with DMHCA administration, significantly augmented cholesterol export and lowered REC cholesterol levels even further when compared to DMHCA treatment alone ( Figure 4B ).
In addition to augmenting cholesterol export, FMC in REC prevented the upregulation of the NF-kβ dependent pro-inflammatory gene, VCAM1 ( Figure 3C) . Importantly, data shown in SRT1720 has been previously shown to increase lifespan and improve overall health in mice fed a high fat diet as well as those fed a normal diet (24, 25) . Activation of SIRT1, via SRT1720, has been shown to significantly improve insulin sensitivity, lower glucose levels and increase mitochondrial and metabolic function (26) . SRT1720 was shown to activate SIRT1 with potencies 1,000-fold greater than resveratrol, another SIRT1 activator (26) . Although administration of SRT1720 was successful in activating retinal SIRT1 levels in our studies, future work on potential off target effects of SRT1720 treatment is needed. Other groups have shown that SIRT1720 is not a direct activator of SIRT1 in non-retinal tissue. Additionally, Pacholec et.
al. suggests that activation of SIRT1 via SRT1720 does not lower plasma glucose nor improve mitochondrial capacity in high fat diet fed mice (27) . In contrast, others have shown SRT1720
as a potential therapeutic agent for type 2 diabetic individuals (26) . There is contradictory evidence as to the pro-survival properties of SIRT1 activation. Zarse et al. demonstrated the negative effects that SRT1720 has on C. elegans lifespan (28) . However, this group also showed that treatment with resveratrol increased C. elegans lifespan, suggesting that in this specific model organism, the effects seen by SIRT1 activation via resveratrol cannot be duplicated by SRT1720. These confounding effects could be due to the governing role that SIRT1 plays in regulating circadian rhythm in peripheral tissues. Several studies have demonstrated SIRT1 activation of BMAL1 and CLOCK genes, resulting in robust circadian restoration (29, 30). Thus, differences in timing and feeding patterns among different studies could result in varied physiological outcomes.
In addition to pharmacological activation of SIRT1, we show that FMCs activate SIRT1/LXRα signaling in retinal endothelial and neuronal cells (Figure 3 ). This finding is particularly exciting due to the numerous studies highlighting the beneficial effects intermittent fasting and calorie restriction regimes have on preventing diabetes-associated complications (20, (31) (32) (33) . Recently, the beneficial effects of calorie restriction were highlighted by a clinical trial in which subjects who maintained reduced caloric intake for two years had a significant reduction in heart disease and diabetes prevalence (34) . However, the mechanism of action responsible for these beneficial effects are still under active investigation. 
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STAR Methods
Animal studies
All animal procedures were in compliance with the National Institutes of Health R28 cells were cultured in DMEM+ media with 10% calf serum. Cells were treated with diabetic relevant stimuli tumor necrosis factor alpha for 24 h (10 ng/ml) (2279-BT; R&D Systems) (39) .
Cell death assay
BREC were cultured in FMC and after the treatment period cell death was analyzed via
Trypan Blue Exclusion Assay (40) . Cell death was calculated by diving the number of dead cells over the total number of cells.
qRT-PCR
RNA was isolated according with the RNeasy mini kit (74106; Qiagen, Valencia, CA)
according to manufacturer's instructions. First-strand complementary DNA was synthesized from isolated RNA using SuperScript II reverse transcription (18064014; Invitrogen). Prepared cDNA was mixed with 2 × SYBR Green PCR Master Mix (4309155; Applied Biosystems) and various sets of gene-specific forward and reverse primers (SIRT1, ABCA1, ABCG1, VCAM1) (Integrated DNA Technologies; Coralville, IA)) ( Table 1 ) and subjected to real-time PCR quantification using the ABI PRISM 7700 Sequence Detection System (Applied Biosystems). All reactions were performed in triplicate. Cyclophilin A was used as a control, and results were analyzed using the comparative Ct method and Ct values were normalized to Cyclophilin A levels. Data is shown as normalized relative to control levels or as non-normalized raw expression levels.
Western Blot and IP
BREC were cultured and treated as necessary. Lysates were collected by scraping cells using cold 1 × radioimmunoprecipitation assay buffer with protease and phosphatase inhibitor (89900; Thermo Scientific). Bradford protein assay was used to measure total protein level and equal amounts of protein (25 μg 
HDAC assay
SIRT1 activity assay was measured using the Histone Deacetylase Activity Assay Kit (ABCAM; ab156064) according to the manufacturer's instructions. Briefly, 300,000 cells were used for each condition. HDAC assay buffer and substrate was added to each sample and incubated for 45 minutes. Fluorescence intensity was measured at Ex/Em 355/460nm. Total protein was used as a normalization for each sample (mg/ml).
Mitochondrial respiration measurements
Respiration of BREC's was measured using an open-shell microrespirometer as previously described (41) . Briefly, BREC at passage 4 were seeded and cultured on fibronectin-coated chips overnight at 37° C, 95% RH, 5% CO2. On the day of measurements, the chips were closed, mounted in a microrespirometer, and immediately perfused at a constant 10 µL/min flow rate.
Perfusion was controlled by a Harvard Apparatus syringe infusion pump. Cells were first perfused with 10% FBS media for 12 hours, followed by perfusion with serum-free media for an additional 24 hours. Respiratory activity was measured for 15 minutes in stationary medium, with a minimum of 15 minutes of re-perfusion between measurements. Total oxygen concentration was maintained above 200 µM in all cases. Measurements in the presence of potassium cyanide (KCN, 5 µM) were used to correct for non-mitochondrial oxygen consumption. Respiratory activity was calculated by linear fitting of the initial five minutes of steady oxygen consumption. Instrument was calibrated used air-equilibrated media as an aerobic standard and 1 mM sodium dithionite in media as anaerobic standard.
Cholesterol measurement
In vivo
Lipid extraction
Lipids from mouse retinas were extracted with methanol, chloroform, and water as previously described (42) . Prior to tissue homogenization, each retina was spiked with 100 nanograms of 19-hydroxycholesterol (Cayman Chemical, Ann Arbor, MI) for quantitation of sterols. Retina lipid extracts were subjected to alkaline hydrolysis of sterol esters for analysis of total sterol content according to (43) .
Analysis of Free and Total Sterol Content
Sterols were analyzed by high resolution/accurate mass LC-MS/MS using a Thermo Scientific LTQ-Orbitrap Velos LC-MS system. Gradient conditions, peak finding, and quantitation were performed as previously described (44) . Cholesterol identification was performed by comparison of retention time, exact mass, and MS
In vitro
Total cholesterol levels were measured using the Amplex Red Cholesterol Assay kit (ThermoFisher Scientific; A12216) according to the manufacturer's instructions. Briefly, cells were diluted in 1X reaction buffer and incubated with a working solution containing 300uM
Amplex Red reagent. Fluorescence was measured at 590nM after 45 minutes at 37°C.
Immunohistochemical staining
Retinas were removed from eyes of euthanized mice with 6 months duration of diabetes. Retinas were embedded in OCT medium and retinal sections (12μm thickness) were 
Visual function studies
Electroretinogram (ERG)
For full-field ERG recordings, mice were dark adapted for 12 h. In preparation for the ERGs, the mice were anesthetized with intraperitoneal (IP) injections of ketamine and xylazine.
The pupils were dilated with 1% atropine sulfate and 2.5% phenylephrine hydrochloride ophthalmic solution which also reduced sensitivity of the eyes to touch. When fully anesthetized, the mice were placed on a stand in a LED Ganzfeld stimulator (LKC Technologies, Gaithersburg, MD). A drop of Goniotaire solution (from Altaire pharmaceuticals and contains 2.5%
hypromellose solution) was applied to each eye to ensure a good electrical connection between the electrodes and the eyes. Animals were kept on a warm (37°C) heating pad during the procedure. Full-field ERGs were recorded from both eyes using the LKC system. Corneal electrodes with contact lenses were placed on each eye, and a steel subdermal needle served as the reference electrode. For grounding, a steel needle was placed in the tail.
To test scotopic responses, animals received a series of flashes at intensities -20db, -10db
and 0db. For photopic responses, flashes were at intensities -3, 3, 6 and 10db after 5 minutes of light adaptation. The inter-stimulus intervals were longer and with fewer trials at higher intensities to reduce bleaching of rod photopigments (45).
Optomotor response
The visual acuity of the mice was determined by use of optomotor response recordings (46, 47) . This was quantified from the spatial frequency as measured by a trained observer- Endothelial cells were cultured on-chip and probed for substrate-supported respiratory activity in the presence of serum (control) and 24 hours after removal of serum (FMC). Potassium cyanide (inhibited) illustrates mitochondrial independent oxygen consumption.
